Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Bausch Health Companies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Bausch Health Companies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Bausch Health Companies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Bausch Health Companies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Bausch Health Companies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Bausch Health Companies Inc, Medical Equipment, Deal Details 15
Asset Purchase 15
Valeant Pharma to Acquire Rights to IBSchek in US and Canada form Commonwealth Labs 15
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 16
Valeant Pharma to Acquire Dental Whitening Business from Klox Technologies 17
Private Equity 18
Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management 18
Partnerships 19
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 19
Namtall Enters into Licensing Agreement with Valeant Pharma 21
Bausch & Lomb Enters Into Licensing Agreement With Cirle 22
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 23
Swedish Orphan Biovitrum Enters into Distribution Agreement with PharmaSwiss 24
Synergetics USA Enters Into Agreement With Cleveland Clinic To Develop Next Generation Intraoperative Devices 25
Valeant Pharmaceuticals International Partners With Living Proof 26
Obagi Medical Products Extends Distribution Agreement With Suneva Medical 27
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 28
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 29
Obagi Medical Products Enters Into Distribution Agreement With Suneva Medical For ReGenica Facial Rejuvenation Complex 30
Solta Medical Expands Co-Marketing Agreement With SkinCeuticals 31
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 32
Sinclair IS Pharma Enters Into Distribution Agreement With Valeant Pharma For Injectable Dermal Fillers 33
Solta Medical Enters Into Co-Marketing Agreement With SkinCeuticals 34
OrthoScan Enters Into Distribution Agreement With Ziehm Imaging 35
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 36
Equity Offering 37
Valeant Pharma Plans to Raise Funds through Public Offering of Securities 37
Bausch & Lomb Withdraws IPO 38
Solta Medical Completes Public Offering Of Common Stock For US$17 Million 39
Debt Offering 40
Valeant Pharma Raises USD586.5 Private Placement of 8.5% Notes Due 2027 40
Valeant Pharma Raises USD1.17 Billion in Private Placement of 9.25% Senior Notes Due 2026 41
Valeant Pharma Raises USD1.18 Billion in Private Placement of 9% Notes Due 2025 42
Valeant Pharma Raises USD591.4 Million in Private Placement of 5.5% Notes Due 2025 43
Valeant Pharma Raises USD801.4 Million in Private Placement of Notes 44
Valeant Pharma Raises USD1.5 Billion in Public Offering of 7% Notes Due 2024 45
Valeant Pharma Raises USD1 Billion in Public Offering of 6.5% Notes Due 2022 46
Solta Medical Completes Private Placement Of Debt Securities For US$40 Million 47
Valeant Pharma Completes Private Placement Of Notes Due 2020 For US$1.75 Billion 48
Valeant Pharma Completes Private Placement Of Notes Due 2020 For US$500 Million 49
Asset Transactions 50
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 50
Valeant Pharma May Sell its Eye-Surgery Equipment Business for up to USD2.5 Billion 51
Almirall Plans to Acquire Dermatology Assets from Valeant Pharmaceuticals 52
Stryker Acquires Neuro Portfolio Assets of Synergetics 53
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 54
Acquisition 55
Valeant Pharma Sells Sprout Pharma 55
Pershing Square Capital Management Sells its Investment in Valeant Pharma 56
Bausch & Lomb Acquires Doctor’s Allergy Formula 57
Valeant Pharma Acquires Synergetics 58
Valeant Pharma to Acquire Unilens Vision 60
Valeant Canada Acquires CROMA Pharma Canada 61
Valeant Pharma Completes Acquisition Of Solta Medical For US$250 Million 62
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 64
Synergetics USA Acquires M.I.S.S. Ophthalmics For US$3 Million 66
OlainFarm Acquires Additional 23.37% Stake In Silvanols, Pharma Products Manufacturer 67
Valeant Pharma Acquires Croma-Pharma Polska And Croma Romania From Croma-Pharma 68
Solta Medical Completes Acquisition Of Sound Surgical For Up To US$40 Million 69
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 70
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 72
Jelfa Acquires Emo-Farm From ICN Polfa Rzeszow For US$10 Million 74
Valeant Pharma Completes Acquisition Of Orapharma From Water Street Healthcare Partners For US$442 Million 75
Bausch Health Companies Inc – Key Competitors 76
Bausch Health Companies Inc – Key Employees 77
Bausch Health Companies Inc – Locations And Subsidiaries 78
Head Office 78
Other Locations & Subsidiaries 78
Recent Developments 87
Financial Announcements 87
May 08, 2018: Valeant Announces First-Quarter 2018 Results And Raises Revenue And Adjusted EBITDA (non-GAAP) Guidance 87
Feb 28, 2018: Valeant Announces Fourth-Quarter And Full-Year 2017 Financial Results 90
Nov 07, 2017: Valeant Announces Third-Quarter 2017 Results 94
Aug 08, 2017: Valeant Announces Second-Quarter 2017 Results 96
May 09, 2017: Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range 99
Feb 28, 2017: Valeant Reports Fourth Quarter And Full Year 2016 Financial Results And Provides 2017 Guidance 100
Corporate Communications 104
Sep 15, 2017: Valeant Commits $200,000 to Support Hurricane Relief Efforts 104
Jun 22, 2017: Bausch + Lomb Named Most Trusted Contact Lens Solution Brand In Canada For Second Consecutive Year By Brandspark International 105
Jun 19, 2017: Valeant Appoints Arthur J. Shannon As Senior Vice President, Head Of Investor Relations And Communications 106
Jun 19, 2017: John Paulson Joins Valeant Board Of Directors 107
May 05, 2017: Valeant Announces Key Appointments In Dermatology And Corporate Communications Leadership 108
Jan 04, 2017: Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors 109
Legal and Regulatory 110
Sep 28, 2018: Salix Resolves Legacy SEC Investigation With No Penalty 110
May 15, 2018: Kyros Law Announces that it is Filing Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors 111
May 08, 2018: Valeant Will Become Bausch Health Companies 112
Apr 12, 2018: Cosmo Pharmaceuticals announces unfavourable award of Arbitral Tribunal in respect of request to terminate Uceris License Agreement with Valeant 113
Product News 114
Apr 27, 2018: Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting 114
May 22, 2017: Bausch + Lomb Introduces renu Advanced Formula Multi-Purpose Solution 116
Other Significant Developments 117
Sep 27, 2018: Bausch Health Releases First Annual Corporate Social Responsibility Report 117
Nov 15, 2017: Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program 118
Appendix 119
Methodology 119
About GlobalData 119
Contact Us 119
Disclaimer 119
Bausch Health Companies Inc, Medical Equipment, Key Facts, 2017 2
Bausch Health Companies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Bausch Health Companies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Bausch Health Companies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Bausch Health Companies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Bausch Health Companies Inc, Deals By Market, 2012 to YTD 2018 11
Bausch Health Companies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Valeant Pharma to Acquire Rights to IBSchek in US and Canada form Commonwealth Labs 15
Valeant Pharma Acquires Medical Devices And Food Supplements Assets Of Croma-Pharma 16
Valeant Pharma to Acquire Dental Whitening Business from Klox Technologies 17
Valeant Pharma Rejects Joint Takeover Bid from Takeda Pharma and TPG Capital Management 18
Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 19
Namtall Enters into Licensing Agreement with Valeant Pharma 21
Bausch & Lomb Enters Into Licensing Agreement With Cirle 22
Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 23
Swedish Orphan Biovitrum Enters into Distribution Agreement with PharmaSwiss 24
Synergetics USA Enters Into Agreement With Cleveland Clinic To Develop Next Generation Intraoperative Devices 25
Valeant Pharmaceuticals International Partners With Living Proof 26
Obagi Medical Products Extends Distribution Agreement With Suneva Medical 27
Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 28
Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 29
Obagi Medical Products Enters Into Distribution Agreement With Suneva Medical For ReGenica Facial Rejuvenation Complex 30
Solta Medical Expands Co-Marketing Agreement With SkinCeuticals 31
Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 32
Sinclair IS Pharma Enters Into Distribution Agreement With Valeant Pharma For Injectable Dermal Fillers 33
Solta Medical Enters Into Co-Marketing Agreement With SkinCeuticals 34
OrthoScan Enters Into Distribution Agreement With Ziehm Imaging 35
Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 36
Valeant Pharma Plans to Raise Funds through Public Offering of Securities 37
Bausch & Lomb Withdraws IPO 38
Solta Medical Completes Public Offering Of Common Stock For US$17 Million 39
Valeant Pharma Raises USD586.5 Private Placement of 8.5% Notes Due 2027 40
Valeant Pharma Raises USD1.17 Billion in Private Placement of 9.25% Senior Notes Due 2026 41
Valeant Pharma Raises USD1.18 Billion in Private Placement of 9% Notes Due 2025 42
Valeant Pharma Raises USD591.4 Million in Private Placement of 5.5% Notes Due 2025 43
Valeant Pharma Raises USD801.4 Million in Private Placement of Notes 44
Valeant Pharma Raises USD1.5 Billion in Public Offering of 7% Notes Due 2024 45
Valeant Pharma Raises USD1 Billion in Public Offering of 6.5% Notes Due 2022 46
Solta Medical Completes Private Placement Of Debt Securities For US$40 Million 47
Valeant Pharma Completes Private Placement Of Notes Due 2020 For US$1.75 Billion 48
Valeant Pharma Completes Private Placement Of Notes Due 2020 For US$500 Million 49
Valeant Pharma International May Sell Eye Surgery Assets to Carl Zeiss Meditec 50
Valeant Pharma May Sell its Eye-Surgery Equipment Business for up to USD2.5 Billion 51
Almirall Plans to Acquire Dermatology Assets from Valeant Pharmaceuticals 52
Stryker Acquires Neuro Portfolio Assets of Synergetics 53
Galderma Completes Acquisition of Aesthetic Dermatology Assets from Valeant Pharma for USD1.4 Billion 54
Valeant Pharma Sells Sprout Pharma 55
Pershing Square Capital Management Sells its Investment in Valeant Pharma 56
Bausch & Lomb Acquires Doctor’s Allergy Formula 57
Valeant Pharma Acquires Synergetics 58
Valeant Pharma to Acquire Unilens Vision 60
Valeant Canada Acquires CROMA Pharma Canada 61
Valeant Pharma Completes Acquisition Of Solta Medical For US$250 Million 62
Valeant Pharma Completes Acquisition Of Bausch & Lomb For US$ 8.7 Billion 64
Synergetics USA Acquires M.I.S.S. Ophthalmics For US$3 Million 66
OlainFarm Acquires Additional 23.37% Stake In Silvanols, Pharma Products Manufacturer 67
Valeant Pharma Acquires Croma-Pharma Polska And Croma Romania From Croma-Pharma 68
Solta Medical Completes Acquisition Of Sound Surgical For Up To US$40 Million 69
Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For US$631 Million 70
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 72
Jelfa Acquires Emo-Farm From ICN Polfa Rzeszow For US$10 Million 74
Valeant Pharma Completes Acquisition Of Orapharma From Water Street Healthcare Partners For US$442 Million 75
Bausch Health Companies Inc, Key Competitors 76
Bausch Health Companies Inc, Key Employees 77
Bausch Health Companies Inc, Other Locations 78
Bausch Health Companies Inc, Subsidiaries 78
List of Figures
Bausch Health Companies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Bausch Health Companies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Bausch Health Companies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Bausch Health Companies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Bausch Health Companies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Bausch Health Companies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Bausch Health Companies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Bausch Health Companies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11